Literature DB >> 23381028

Cardiovascular endocrinology: tailoring antihypertensive drug treatment to body size.

Guido Grassi, Giuseppe Mancia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23381028     DOI： 10.1038/nrendo.2013.18

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

Review 1.  New-onset diabetes and antihypertensive drugs.

Authors:  Giuseppe Mancia; Guido Grassi; Alberto Zanchetti
Journal:  J Hypertens       Date:  2006-01       Impact factor: 4.844

2.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Serap Erdine; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Lars H Lindholm; Margus Viigimaa; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Bernard Waeber; Bryan Williams
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

3.  Diuretic-based regimens for obese patients?

Authors:  Franz H Messerli; Sripal Bangalore
Journal:  Lancet       Date:  2012-12-06       Impact factor: 79.321

4.  Obesity-related hypertension: epidemiology, pathophysiology, and clinical management.

Authors:  Theodore A Kotchen
Journal:  Am J Hypertens       Date:  2010-08-12       Impact factor: 2.689

5.  Adrenergic and reflex abnormalities in obesity-related hypertension.

Authors:  G Grassi; G Seravalle; R Dell'Oro; C Turri; G B Bolla; G Mancia
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

6.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors:  Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

7.  Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.

Authors:  Michael A Weber; Kenneth Jamerson; George L Bakris; Matthew R Weir; Dion Zappe; Ying Zhang; Bjorn Dahlof; Eric J Velazquez; Bertram Pitt
Journal:  Lancet       Date:  2012-12-06       Impact factor: 79.321

8.  European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions.

Authors:  Markus P Schlaich; Guido Grassi; Gavin W Lambert; Nora Straznicky; Murray D Esler; John Dixon; Elisabeth A Lambert; Josep Redon; Krzysztof Narkiewicz; Jens Jordan
Journal:  J Hypertens       Date:  2009-02       Impact factor: 4.844

9.  Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.

Authors:  Jens Jordan; Volkan Yumuk; Markus Schlaich; Peter M Nilsson; Barbara Zahorska-Markiewicz; Guido Grassi; Roland E Schmieder; Stefan Engeli; Nick Finer
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.